Skip to content
Blue Beat GroupBlue Beat Group
      • Our Philosophy
      • Portfolio
      • Focus Areas
      • Team
      • News
      • About SGI
      • Contact Us
        Sgi News 02
        NewNews & BlogPress Release

        SPRIM Global Investments names Susan Dallabrida as Chief Executive Officer of SPRIM Consultancy

        NEW YORK – February 8, 2022 – SPRIM Global Investments announces the promotion of Susan Dallabrida, PhD, to Chief Executive Officer of SPRIM Consultancy. In her nearly 2 years with SPRIM, Susan has brought both scientific and commercial leadership to the business, boosting revenue while strengthening the company’s skill sets in clinical science and innovation. In…

        Read More
      • News & Blog
      • Digital & AI
        News & BlogPress Release
        Post Hero

        BAC and Blade Announce Definitive Merger Agreement

        Read More
        News & BlogPress Release
        Sgi Portfolio Logo Aumbiosciences

        AUM Biosciences announces closing of $27 million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

        Read More
        News & BlogPress Release
        Leveraging Next Gen Tools In Rare Disease Research

        Leveraging Next-Gen Tools in Rare Disease Research

        Read More
        News & BlogPress Release
        Sgi Portfolio Logo Fibronostics

        Fibronostics Raises $8 Million in Series A Financing

        Read More
        News & BlogPress Release
        The Critical Need For Virtual Covid 19 Clinical Trials And Patient Training

        The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training

        Read More
        News & BlogPress Release
        Obviohealth And Hôpital Paris Saint Joseph Announce Partnership To Track Covid 19 In Oncology Patients

        ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients

        Read More
        News & BlogPress Release
        Travecta Therapeutics Announces It Has Closed Its Oversubscribed Series A Round At $27 Million

        Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million

        Read More
        News & BlogPress Release
        Sprim Partners With Health Catalyst To Analyze Covid 19 Impact On Nash And Nafld

        SPRIM Partners with Health Catalyst to Analyze COVID-19 Impact on NASH and NAFLD

        Read More
        News & BlogPress Release
        Sgi Portfolio Logo Obviohealth

        ObvioHealth Secures $17 Million in Latest Investment Round

        Read More
        News & BlogPress Release
        Sgi Portfolio Logo Travecta

        Travecta Therapeutics Secures $15 Million in Financing

        Read More
      Sprim Global Investments Logo

      Invest

      Portfolio

      Company

      About Us
      Our Philosophy
      Our Focus Areas
      Our Team

      Resources

      News & Blogs
      Digital & Ai
      SPRIM Global Investment © 2023. All Rights Reserved
      Privacy Policy | Terms & Conditions | Contact Us
      • Our Philosophy
      • Portfolio
      • Focus Areas
      • Team
      • News
      • About SGI
      • Contact Us